Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A lysine methyltransferase 2 (EEF1AKMT2), also known as METTL10, is an enzyme that catalyzes the trimethylation of lysine-318 on the eukaryotic translation elongation factor 1 alpha (EEF1A). This protein is part of the class I-like S-adenosyl methionine (SAM)-binding methyltransferase superfamily, specifically within the EFM4 family. EEF1AKMT2 is a cytosolic and nucleoplasmic protein involved in protein lysine methylation, which is important for regulating the structure and function of modified proteins. Its best-characterized substrate is EEF1A, a key translational GTPase in mRNA translation. No direct drug interactions or disease associations have been established based on current genomic databases and literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EEF1A lysine methyltransferase 2 (EEF1AKMT2).